PC Jeweller Limited (BOM:534809)
India · Delayed Price · Currency is INR 14.75
-0.27 (-1.80%)
At close: Aug 4, 2025
Longboard Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 25,684 | 22,446 | 6,054 | 24,727 | 16,061 | 28,263 | Upgrade |
Revenue | 25,684 | 22,446 | 6,054 | 24,727 | 16,061 | 28,263 | Upgrade |
Revenue Growth (YoY) | 173.56% | 270.76% | -75.52% | 53.95% | -43.17% | -45.72% | Upgrade |
Cost of Revenue | 20,138 | 17,671 | 6,754 | 20,886 | 14,120 | 22,741 | Upgrade |
Gross Profit | 5,546 | 4,775 | -699.7 | 3,841 | 1,942 | 5,523 | Upgrade |
Selling, General & Admin | 273.1 | 257.9 | 465.7 | 739.6 | 562 | 521.9 | Upgrade |
Other Operating Expenses | 570.2 | 571.4 | 540.1 | 618.8 | 2,332 | 557.9 | Upgrade |
Operating Expenses | 1,036 | 1,009 | 1,210 | 1,631 | 3,172 | 1,429 | Upgrade |
Operating Income | 4,510 | 3,766 | -1,909 | 2,210 | -1,230 | 4,094 | Upgrade |
Interest Expense | -911.4 | -512.9 | -5,046 | -4,917 | -4,323 | -3,770 | Upgrade |
Interest & Investment Income | - | - | 65.9 | 56.1 | 53.9 | 88.4 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 286.1 | 1,447 | 389.4 | -315.4 | Upgrade |
Other Non Operating Income (Expenses) | 1,716 | 1,273 | 96.7 | 37.3 | -10.9 | -34.8 | Upgrade |
EBT Excluding Unusual Items | 5,315 | 4,526 | -6,506 | -1,166 | -5,121 | 62.2 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 3.2 | - | 0.2 | 0.4 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 185.1 | 87 | 0.1 | -0.1 | Upgrade |
Other Unusual Items | - | - | - | - | 39.8 | 15.6 | Upgrade |
Pretax Income | 5,315 | 4,526 | -6,318 | -1,079 | -5,080 | 78.1 | Upgrade |
Income Tax Expense | -520.7 | -1,251 | -24.1 | 952.7 | -1,170 | -541.9 | Upgrade |
Net Income | 5,836 | 5,777 | -6,294 | -2,032 | -3,910 | 620 | Upgrade |
Net Income to Common | 5,836 | 5,777 | -6,294 | -2,032 | -3,910 | 620 | Upgrade |
Net Income Growth | - | - | - | - | - | -25.34% | Upgrade |
Shares Outstanding (Basic) | 5,549 | 5,112 | 4,654 | 4,654 | 4,654 | 4,056 | Upgrade |
Shares Outstanding (Diluted) | 10,101 | 8,753 | 4,654 | 4,654 | 4,654 | 4,065 | Upgrade |
Shares Change (YoY) | 116.90% | 88.07% | - | - | 14.50% | 2.72% | Upgrade |
EPS (Basic) | 1.05 | 1.13 | -1.35 | -0.44 | -0.84 | 0.15 | Upgrade |
EPS (Diluted) | 0.58 | 0.66 | -1.35 | -0.44 | -0.84 | 0.15 | Upgrade |
EPS Growth | - | - | - | - | - | -27.22% | Upgrade |
Free Cash Flow | - | -6,333 | 637.3 | 965.8 | -7,231 | 904.5 | Upgrade |
Free Cash Flow Per Share | - | -0.72 | 0.14 | 0.21 | -1.55 | 0.22 | Upgrade |
Gross Margin | 21.59% | 21.27% | -11.56% | 15.53% | 12.09% | 19.54% | Upgrade |
Operating Margin | 17.56% | 16.78% | -31.54% | 8.94% | -7.66% | 14.48% | Upgrade |
Profit Margin | 22.72% | 25.74% | -103.96% | -8.22% | -24.34% | 2.19% | Upgrade |
Free Cash Flow Margin | - | -28.21% | 10.53% | 3.91% | -45.02% | 3.20% | Upgrade |
EBITDA | 4,723 | 3,945 | -1,864 | 2,279 | -1,149 | 4,232 | Upgrade |
EBITDA Margin | 18.39% | 17.58% | -30.78% | 9.22% | -7.15% | 14.97% | Upgrade |
D&A For EBITDA | 212.95 | 179.5 | 45.7 | 68.9 | 80.8 | 138.7 | Upgrade |
EBIT | 4,510 | 3,766 | -1,909 | 2,210 | -1,230 | 4,094 | Upgrade |
EBIT Margin | 17.56% | 16.78% | -31.54% | 8.94% | -7.66% | 14.48% | Upgrade |
Revenue as Reported | 27,400 | 23,719 | 6,699 | 26,359 | 16,589 | 28,504 | Upgrade |
Advertising Expenses | - | - | 5.6 | 121.5 | 39.1 | 51.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.